Skip to main content
Premium Trial:

Request an Annual Quote

Eurogentec Reaches Deal to Buy AnaSpec

NEW YORK (GenomeWeb News) – Eurogentec said today that it has reached an agreement to acquire proteomics company AnaSpec for an undisclosed sum.

The agreement will give Eurogentec the potential to offer both genomics and proteomics tools for biotech, pharmaceutical, and diagnostics markets, the company said.

AnaSpec, based in Fremont, Calif., provides integrated proteomics solutions and specializes in peptide synthesis, labeled peptides and antibodies, fluorescent dyes, enzymatic activities, and assays for basic research, high-throughput screening, and drug discovery.

Eurogentec said it plans to maintain AnaSpec's facility and employees in Fremont, and that AnasSpec's co-founders, President Anita Hong and CEO Frank Hong, will remain with the company in leading roles.

Eurogentec CEO Jean-Pierre Delwart said in a statement that the deal "considerably strengthens Eurogentec's geographical presence in the US," and the company will market and support AnaSpec's products in Europe.

Financial terms of the agreement were not released.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.